Solid Biosciences Statistics
Total Valuation
SLDB has a market cap or net worth of $585.11 million. The enterprise value is $390.38 million.
Important Dates
The last earnings date was Friday, March 6, 2026, after market close.
| Earnings Date | Mar 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SLDB has 77.91 million shares outstanding. The number of shares has increased by 111.62% in one year.
| Current Share Class | 77.91M |
| Shares Outstanding | 77.91M |
| Shares Change (YoY) | +111.62% |
| Shares Change (QoQ) | +0.29% |
| Owned by Insiders (%) | 1.24% |
| Owned by Institutions (%) | 54.94% |
| Float | 41.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.77 |
| P/TBV Ratio | 2.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.74, with a Debt / Equity ratio of 0.10.
| Current Ratio | 6.74 |
| Quick Ratio | 6.50 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,262.65 |
Financial Efficiency
Return on equity (ROE) is -86.83% and return on invested capital (ROIC) is -49.15%.
| Return on Equity (ROE) | -86.83% |
| Return on Assets (ROA) | -43.67% |
| Return on Invested Capital (ROIC) | -49.15% |
| Return on Capital Employed (ROCE) | -71.43% |
| Weighted Average Cost of Capital (WACC) | 18.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.67M |
| Employee Count | 100 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.11% in the last 52 weeks. The beta is 2.76, so SLDB's price volatility has been higher than the market average.
| Beta (5Y) | 2.76 |
| 52-Week Price Change | +40.11% |
| 50-Day Moving Average | 6.36 |
| 200-Day Moving Average | 5.70 |
| Relative Strength Index (RSI) | 58.48 |
| Average Volume (20 Days) | 1,636,392 |
Short Selling Information
The latest short interest is 9.54 million, so 12.25% of the outstanding shares have been sold short.
| Short Interest | 9.54M |
| Short Previous Month | 9.43M |
| Short % of Shares Out | 12.25% |
| Short % of Float | 23.15% |
| Short Ratio (days to cover) | 8.31 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -169.70M |
| Pretax Income | -167.14M |
| Net Income | -167.14M |
| EBITDA | -168.04M |
| EBIT | -169.70M |
| Earnings Per Share (EPS) | -$2.24 |
Full Income Statement Balance Sheet
The company has $236.14 million in cash and $21.94 million in debt, with a net cash position of $214.21 million or $2.75 per share.
| Cash & Cash Equivalents | 236.14M |
| Total Debt | 21.94M |
| Net Cash | 214.21M |
| Net Cash Per Share | $2.75 |
| Equity (Book Value) | 217.95M |
| Book Value Per Share | 2.80 |
| Working Capital | 208.51M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$132.38 million and capital expenditures -$792,000, giving a free cash flow of -$133.17 million.
| Operating Cash Flow | -132.38M |
| Capital Expenditures | -792,000 |
| Free Cash Flow | -133.17M |
| FCF Per Share | -$1.71 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SLDB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -111.62% |
| Shareholder Yield | -111.62% |
| Earnings Yield | -27.64% |
| FCF Yield | -22.03% |
Analyst Forecast
The average price target for SLDB is $15.00, which is 99.73% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 99.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 28, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Oct 28, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |